Blog

Global Think Tank on Steatotic Liver Disease

by Brandon Tudor | June 7, 2025 | News | 0 Comments

Recent news from Barcelona: As a function of the very first Global Think Tank on Steatotic Liver...

MASLD and Type 2 Diabetes

by Brandon Tudor | June 5, 2025 | News | 0 Comments

An article recently published in Diabetes Care highlights the significant interplay between...

Improving QOL For Decompensated Cirrhosis Patients

by Brandon Tudor | June 3, 2025 | News | 0 Comments

Consider the article titled "Decompensated Liver Cirrhosis Care" from Gastroenterology &...

Here at LiverRight, we believe in swift access to diagnosis and care for adults who might be at risk for liver disease, via same-week video visits. Across all 50 US states. From the Gastroenterology Learning Network 03/14/2025 article by Jessica Garlewicz, titled...

New study finds alcohol-related liver disease on rise in young adults

by Brandon Tudor | Mar 14, 2025 |

Good summary from the folks at WITN-- https://youtu.be/Zp6p7TKT_hQ?si=IlxDM79XOaPOh7je

Efruxifermin reverses MASH-related cirrhosis in Phase 2

by Brandon Tudor | Mar 12, 2025 |

Efruxifermin reverses MASH-related cirrhosis in Phase 2 trial, per a recent press release from Akero Therapeutics. Treatment with Akero Therapeutics’ investigational efruxifermin led to reversals of compensated cirrhosis, or irreversible scarring in a...

Quick Links

Our Team
About 
Careers
Contact